Stock Taper
Latest 13F filing data - Q2 2026
| STOCK | TICKER | SHARES HELD▲ ▼ | VALUE▲ ▼ |
|---|---|---|---|
NewAmsterdam Pharma Company N.V. | NAMS | 8.49M | $287.74M |
Aura Biosciences, Inc. | AURA | 4.05M | $28.78M |
Dyne Therapeutics, Inc. | DYN | 3.85M | $85.47M |
MapLight Therapeutics, Inc. | MPLT | 3.23M | $115.63M |
Replimune Group, Inc. | REPL | 2.81M | $31.09M |